Champions Oncology Correlations

CSBR Stock

USD 11.07 0.01 0.09%

The current 90-days correlation between Champions Oncology and Molecular Partners AG is -0.02 (i.e., Good diversification). The correlation of Champions Oncology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Champions Oncology Correlation With Market

Significant diversification

The correlation between Champions Oncology and DJI is 0.01 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Champions Oncology and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Champions Oncology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

To learn how to invest in Champions Stock, please use our How to Invest in Champions Oncology guide.

Moving together with Champions Stock

0.65	A	Agilent Technologies Earnings Call This Week	Pair Corr
0.77	DRTS	Alpha Tau Medical	Pair Corr
0.65	VSTM	Verastem	Pair Corr
0.78	DNA	Ginkgo Bioworks Holdings Buyout Trend	Pair Corr
0.64	PFE	Pfizer Inc	Pair Corr

Moving against Champions Stock

0.86	ERAS	Erasca Inc	Pair Corr
0.81	EWTX	Edgewise Therapeutics Earnings Call This Week	Pair Corr
0.7	ESPR	Esperion Therapeutics Earnings Call This Week	Pair Corr
0.69	DSGN	Design Therapeutics	Pair Corr
0.61	VRDN	Viridian Therapeutics Earnings Call This Week	Pair Corr
0.59	EXEL	Exelixis	Pair Corr
0.41	VTYX	Ventyx Biosciences	Pair Corr
0.39	ERNA	Eterna Therapeutics	Pair Corr
0.38	ME	23Andme Holding	Pair Corr
0.95	CGC	Canopy Growth Corp	Pair Corr
0.92	HCM	HUTCHMED DRC	Pair Corr
0.88	FDMT	4D Molecular Therapeutics	Pair Corr
0.85	FHTX	Foghorn Therapeutics Trending	Pair Corr
0.84	FLGC	Flora Growth Corp	Pair Corr
0.76	RNA	Avidity Biosciences	Pair Corr
0.52	MRK	Merck Company	Pair Corr
0.51	AIM	AIM ImmunoTech	Pair Corr
0.49	AQB	AquaBounty Technologies	Pair Corr

Related Correlations Analysis

	MOLN	MNOV	ANEB	CYT	PRDS	STTK	ELYM	IPSC	AVTE	ADAG
MOLN		0.02	0.09	0.0	0.0	-0.21	0.0	0.68	0.22	0.62	MOLN
MNOV	0.02		-0.31	0.0	0.0	0.08	0.0	0.42	0.32	0.19	MNOV
ANEB	0.09	-0.31		0.0	0.0	0.28	0.0	-0.08	0.28	0.0	ANEB
CYT	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	CYT
PRDS	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	PRDS
STTK	-0.21	0.08	0.28	0.0	0.0		0.0	-0.11	0.04	-0.06	STTK
ELYM	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	ELYM
IPSC	0.68	0.42	-0.08	0.0	0.0	-0.11	0.0		0.55	0.86	IPSC
AVTE	0.22	0.32	0.28	0.0	0.0	0.04	0.0	0.55		0.58	AVTE
ADAG	0.62	0.19	0.0	0.0	0.0	-0.06	0.0	0.86	0.58		ADAG
	MOLN	MNOV	ANEB	CYT	PRDS	STTK	ELYM	IPSC	AVTE	ADAG

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ADAG	+ 0.86	IPSC
IPSC	+ 0.68	MOLN
ADAG	+ 0.62	MOLN
ADAG	+ 0.58	AVTE
AVTE	+ 0.55	IPSC
IPSC	+ 0.42	MNOV

High negative correlations

ANEB	- 0.31	MNOV
STTK	- 0.21	MOLN
IPSC	- 0.11	STTK
IPSC	- 0.08	ANEB
ADAG	- 0.06	STTK
ADAG	- 0.0	ELYM

Risk-Adjusted Indicators

There is a big difference between Champions Stock performing well and Champions Oncology Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Champions Oncology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
MOLN	2.71	(0.33)	0.00	(0.24)	0.00	0.00	7.84	(6.13)	18.67
MNOV	3.39	0.58	0.15	0.86	3.12	(4.57)	6.50	(5.24)	61.30
ANEB	4.14	(0.12)	0.00	(0.08)	0.00	0.00	7.59	(9.76)	40.03
CYT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PRDS	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
STTK	4.58	0.33	0.06	(1.87)	4.90	(5.55)	11.21	(9.01)	22.78
ELYM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
IPSC	3.45	(0.85)	0.00	(0.78)	0.00	0.00	6.29	(7.41)	31.00
AVTE	1.43	(0.15)	0.00	(0.32)	0.00	0.00	4.30	(3.31)	10.45
ADAG	3.38	(0.50)	0.00	(11.26)	0.00	0.00	5.00	(8.25)	41.45

Champions Oncology Corporate Management

Marianna Zipeto	Research Commercial	Profile
Michael MBA	Chief Officer	Profile
Maria Mancini	Chief Operations	Profile
Karin Heidemann	Executive Operations	Profile
Arthur Hanson	Vice Technology	Profile
BS CMAR	Ex Operations	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC